Regeneron Pharmaceuticals Other Inventory, Net increased by 8.3% to $787.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $773.90M to $787.90M. Over 5 years (FY 2020 to FY 2025), Other Inventory, Net shows an upward trend with a 11.0% CAGR.
Significant fluctuations may indicate changes in maintenance requirements, spare parts strategy, or write-downs of obsolete stock.
This category captures miscellaneous inventory items that do not fit into standard raw material, work-in-progress, or fi...
Varies significantly by company depending on accounting policies for spare parts and maintenance supplies.
other_inventory_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $535.00M | $503.70M | $510.00M | $566.50M | $623.90M | $592.80M | $720.70M | $752.30M | $747.90M | $726.20M | $522.10M | $611.50M | $720.70M | $766.70M | $725.70M | $773.90M | $764.40M | $808.80M | $727.50M | $787.90M |
| QoQ Change | — | -5.9% | +1.3% | +11.1% | +10.1% | -5.0% | +21.6% | +4.4% | -0.6% | -2.9% | -28.1% | +17.1% | +17.9% | +6.4% | -5.3% | +6.6% | -1.2% | +5.8% | -10.1% | +8.3% |
| YoY Change | — | — | — | — | +16.6% | +17.7% | +41.3% | +32.8% | +19.9% | +22.5% | -27.6% | -18.7% | -3.6% | +5.6% | +39.0% | +26.6% | +6.1% | +5.5% | +0.2% | +1.8% |